BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioBridge Knowledge Platform - ECPv5.10.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioBridge Knowledge Platform
X-ORIGINAL-URL:https://library.biobridge-event.com/knowledge
X-WR-CALDESC:Events for BioBridge Knowledge Platform
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20211130T183000
DTEND;TZID=Europe/Paris:20211130T193000
DTSTAMP:20260514T000829
CREATED:20211104T131910Z
LAST-MODIFIED:20211105T133650Z
UID:12407-1638297000-1638300600@library.biobridge-event.com
SUMMARY:RegenPRP\, a standardized platelet-rich plasma for Alopecia management
DESCRIPTION:There is great interest in using PRP for the treatment of alopecia due to the low risk of side effects and the need for less frequent application than current treatments. However\, despite promising results in clinical trials\, a standard protocol regarding the dose\, frequency and depth of injection to be used has not yet emerged. This has been impeded due to the myriad of PRP preparations and procedures being used which makes interpretation and comparisons between studies difficult. Moreover\, the etiology of alopecia is complex\, and treatment may need to be adapted depending on the stage of the disease. \nThus\, there is an urgent need for the standardization of PRP preparations and the design of appropriate clinical trials with the necessary controls to evaluate the efficacy of PRP for treatment of hair loss. Nonetheless\, despite these limitations\, a recent systematic review concluded that PRP has demonstrated clinical efficacy and recommends 3 to 4 monthly sessions for the treatment of alopecia (Hesseler and Shyam\, 2020). Regen Lab has initiated studies using the standardized RegenPRP in collaboration with Dr Jerry Shapiro\, NYU Langone\, USA\, with the results from the first study published in 2020 (Shapiro et al.\, 2020). \n\n\n					\n				\n					\n						Our Speaker\n\n\nDr Bruce Reith\,  \nSpecialist in Hair Restoration (Germany) \n\n\n\n\n					\n				\n					\n						TOPICS DISCUSSED : \nI) Gold book: RegenPRP\, a standardized platelet-rich plasma for Alopecia management \n(Mr Gomri\, Biologist\, 5 min)\nA compilation of clinical evidence\, cases and testimonies with the use of a standardized PRP in alopecia. \nII) Dr Bruce Reith expertise in the use of RegenPRP and Cellular Matrix in Alopecia\n(Dr Bruce Reith\, 25 min)\nA track-record expertise in using RegenPRP in Alopecia. \nIII) Q/A session (15min) \nREGISTER NOW >>\n\n					\n				\n					\n						RegenPRP®: Standardized Platelet Rich Plasma for Skin\, Hair & Genitourinary Disorders \nFor professionals involved in the management of patients suffering from skin\, hair\, and genitourinary disorders.
URL:https://library.biobridge-event.com/knowledge/event/regenprp-a-standardized-platelet-rich-plasma-for-alopecia-management/
LOCATION:via Zoom\, Switzerland
END:VEVENT
END:VCALENDAR